Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Category
Equity - Leveraged / Inverse
Sponsor
Defiance ETFs
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
1.49%
Inverse/Leveraged
IPO
Aug 08, 2024
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-1.98%
SMA50
-6.87%
SMA200
3.17%
Return% 1Y
51.54%
Return% 3Y
-
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
4.19%
Flows% 3M
-36.86%
Flows% YTD
16.83%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
9
AUM
41.28M
NAV/sh
52W High
31.19 -23.41%
52W Low
14.51 64.65%
Volatility
5.24% 4.68%
ATR (14)
1.24
RSI (14)
41.61
Beta
0.60
Rel Volume
0.31
Avg Volume
304.30K
Volume
4,751
Perf Week
-6.90%
Perf Month
-2.05%
Perf Quarter
-15.85%
Perf Half Y
35.47%
Perf YTD
-6.28%
Perf Year
41.19%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
23.82
Price
23.89
Change %
0.31%
Apr-22-25 08:07AM
Defiance Daily Target 2X Long LLY ETF seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Eli Lilly and Company. The fund will enter into one or more swap agreements with financial institutions for a specified period, which may range from one day to longer than a year. The advisor has adopted a policy to have at least 80% exposure to financial instruments with economic characteristics that should perform 2X the daily performance of the underlying security's shares. The fund is non-diversified.